CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...